Medical News

Clinical Benefits of Piperacillin/Tazobactam versus a Combin...
‎Int J Gen Med.

Treatment with piperacillin/tazobactam was more effective than that with ceftriaxone plus clindamycin in patients...

25 Sep 2020

Clinical and Imaging Profiles of Pulmonary Embolism: A Singl...
Int J Emerg Med.

This study suggests that patients with obesity and sickle cell disease constitute an important proportion of all PE...

23 Sep 2020

Core-to-Skin Temperature Gradient Measured by Thermography P...
‎J Crit Care.

Core-to-index finger temperature gradient higher than 7 °C predicts day-8 mortality in septic shock and is...

18 Sep 2020

Disease Burden and Prognostic Factors for Clinical Failure i...
‎BMC Infect Dis.

Discordant therapy was a cause of CF. Early accurate detection and management of prevention to potential causes is...

14 Sep 2020

Key Trials

Does Remdesivir Provide a Benefit on Clinical Status for Patients Hospitalized with Moderate COVID-19 Pneumonia?

The present randomized clinical trial studied the effect of remdesivir vs standard care on clinical outcomes at 11 Days in patients with moderate...

Remdesivir Improves Survival Outcomes in ICU Patients with COVID-19 under Mechanical Ventilation

The mortality rate of patients with COVID-19 under mechanical ventilation is high. Treatment with remdesivir resulted in improved survival outcomes...

Recurrent Pseudomonas aeruginosa Infections after Allogenic Hematopoietic Cell Transplantation

The rate of recurrent Pseudomonas aeruginosa (PSA) infections in allogeneic hematopoietic cell transplantation (allo-HCT) recipients is high. The...

Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease

The present trial compared the efficacy and safety outcomes of remdesivir 5 Days verses 10 Days in treatment of patients with severe Covid-19...

Slide Library

Cefuroxime (Novacef)

Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....

 
Email this page
Management of Mucormycosis in ENT Practice

Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...

 
Email this page
Antifungal Therapy in Immunocompromised Patients

Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...

 
Email this page
Disseminated Tuberculosis with ARDS

Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...

 
Email this page

Our Publications

Cytorx (Flucytosine) Monograph

This monograph describes the role of Flucytosine tablets in the management of invasive cryptococcal infections and some Candida spp. infections.  

Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections

Parenteral macrolide therapy is needed for patients with moderate to severe CAP/AECB. This booklet gives an overview of the efficacy and safety of...

MRSA: The Clinician’s Challenge

The article summarizes the Indian epidemiological data for MRSA infections, along with treatment of MRSA infections and infection control measures.

Phosome IV (Liposomal Amphotericin B) Monograph

Amphotericin B deoxycholate has a broad antifungal activity, and today it is the best antifungal available against most systemic fungal infections,...

Poll

Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
25% (2 votes)
Sometimes
25% (2 votes)
No
50% (4 votes)
Total votes: 8